Colin Beirne
Partner
Two Sigma Ventures
Colin Beirne is a Partner at Two Sigma Ventures investing in companies using data and advanced computing across sectors including fintech, AI, robotics, real estate, and healthcare.
Professional summary
Elianna Knight is listed by Two Sigma Ventures as an investor and an M.D. candidate at Yale School of Medicine. Her research includes medical applications of quantum machine learning, latent diffusion models for antibody CDR generation, and prior work on polygenic risk scores and biomarker variation at Stanford. Before TSV, she worked as a data scientist at an Ethereum infrastructure company and as a programmer at a genetics company.
Career, education, and skills
8 more profiles